ADXN Valuation

Addex Therapeutics Ltd (ADXN) has a current Price-to-Book (P/B) ratio of 128.03. Compared to its 3-year average P/B ratio of 28.50 , the current P/B ratio is approximately 349.31% higher. Relative to its 5-year average P/B ratio of 17.89, the current P/B ratio is about 615.79% higher. Addex Therapeutics Ltd (ADXN) has a Forward Free Cash Flow (FCF) yield of approximately -23.30%. Compared to its 3-year average FCF yield of -100.68%, the current FCF yield is approximately -76.86% lower. Relative to its 5-year average FCF yield of -87.58% , the current FCF yield is about -73.40% lower.